Detalhe da pesquisa
1.
Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapies.
Am J Hum Genet
; 109(9): 1638-1652, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055212
2.
Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial.
Gastroenterology
; 166(4): 690-703, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158089
3.
Nonsteroidal anti-inflammatory drugs as a targeted therapy for bone marrow failure in Ghosal hematodiaphyseal dysplasia.
Blood
; 141(13): 1553-1559, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574346
4.
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE).
J Am Soc Nephrol
; 35(1): 74-84, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38088558
5.
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
Int J Cancer
; 154(10): 1794-1801, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38312102
6.
Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
Lancet
; 401(10388): 1595-1609, 2023 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088092
7.
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
Lancet
; 402(10398): 291-303, 2023 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285865
8.
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
Lancet
; 401(10373): 269-280, 2023 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709073
9.
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10399): 373-385, 2023 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311468
10.
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
N Engl J Med
; 384(17): 1601-1612, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913638
11.
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
N Engl J Med
; 384(17): 1589-1600, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913637
12.
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
N Engl J Med
; 385(25): 2325-2335, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739194
13.
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
N Engl J Med
; 385(25): 2313-2324, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739196
14.
IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study.
Rheumatology (Oxford)
; 63(2): 349-357, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37354495
15.
The role of iron in chronic inflammatory diseases: from mechanisms to treatment options in anemia of inflammation.
Blood
; 140(19): 2011-2023, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35994752
16.
The crucial role of NRF2 in erythropoiesis and anemia: Mechanisms and therapeutic opportunities.
Arch Biochem Biophys
; 754: 109948, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452967
17.
Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia Among Patients With Solid Tumors.
J Natl Compr Canc Netw
; 22(3)2024 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489926
18.
Mechanisms of hemoglobin cycling in anemia patients treated with erythropoiesis-stimulating agents.
PLoS Comput Biol
; 19(1): e1010850, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693034
19.
Implementation of post-discharge malaria chemoprevention (PDMC) in Benin, Kenya, Malawi, and Uganda: stakeholder engagement meeting report.
Malar J
; 23(1): 89, 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539181
20.
Anemia-related response end points in myelofibrosis clinical trials: current trends and need for renewed consensus.
Future Oncol
; 20(11): 703-715, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38318719